Lennox-Gastaut syndrome: a comprehensive review - Neurological Sciences
- ️Asadi-Pooya, Ali A.
- ️Thu Nov 09 2017
Gastaut H, Roger J, Soulayrol R, Saint-Jean M, Tassinari CA, Regis H et al (1966) Epileptic encephalopathy of children with diffuse slow spikes and waves (alias “petit mal variant”) or Lennox syndrome. Ann Pediatr (Paris) 13(8):489–499 French. No abstract available
Commission on Classification and Terminology of the International League Against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389–399
Camfield PR (2011) Definition and natural history of Lennox-Gastaut syndrome. Epilepsia 52(Suppl 5):3–9
Arzimanoglou A, French J, Blume WT, Cross JH, Ernst JP, Feucht M et al (2009) Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 8:82–93
Shyu HY, Lin JH, Chen C, Kwan SY, Yiu CH (2011) An atypical case of Lennox-Gastaut syndrome not associated with mental retardation: a nosological issue. Seizure 20(10):820–823
Asadi-Pooya AA, Sharifzade M (2012) Lennox-Gastaut syndrome in south Iran: electro-clinical manifestations. Seizure 21(10):760–763
Heiskala H (1997) Community-based study of Lennox-Gastaut syndrome. Epilepsia 38(5):526–531
Trevathan E, Murphy CC, Yeargin-Allsopp M (1997) Prevalence and descriptive epidemiology of Lennox-Gastaut syndrome among Atlanta children. Epilepsia 38:1283–1288
Crumrine PK (2002) Lennox-Gastaut syndrome. J Child Neurol 17:S70–S75
Goldsmith IL, Zupanc ML, Buchhalter JR (2000) Long-term seizure outcome in 74 patients with Lennox-Gastaut syndrome: effects of incorporating MRI head imaging in defining the cryptogenic subgroup. Epilepsia 41(4):395–399
Camfield CS, Camfield PR, Gordon K, Wirrell E, Dooley JM (1996) Incidence of epilepsy in childhood and adolescence: a population based study in Nova Scotia from 1977 to 1985. Epilepsia 37:19–23
Craven I, Griffiths PD, Hoggard N (2011) Magnetic resonance imaging of epilepsy at 3 Tesla. Clin Radiol 66(3):278–286
Abu Saleh T, Stephen L (2008) Lennox gastaut syndrome, review of the literature and a case report. Head Face Med 4:9
Ferlazzo E, Nikanorova M, Italiano D, Bureau M, Dravet C, Calarese T et al (2010) Lennox-Gastaut syndrome in adulthood: clinical and EEG features. Epilepsy Res 89(2–3):271–277
Widdess-Walsh P, Dlugos D, Fahlstrom R, Joshi S, Shellhaas R, Boro A, EPGP Investigators et al (2013) Lennox-Gastaut syndrome of unknown cause: phenotypic characteristics of patients in the Epilepsy Phenome/Genome Project. Epilepsia 54(11):1898–1904
Lund C, Brodtkorb E, Rosby O, Rodningen OK, Selmer KK (2013) Copy number variants in adult patients with Lennox–Gastaut syndrome features. Epilepsy Res 105(1–2):110–117
Selmer KK, Lund C, Brandal K, Undlien DE, Brodtkorb E (2009) SCN1A mutation screening in adult patients with Lennox–Gastaut syndrome features. Epilepsy Behav 16(3):555–557
Lund C, Brodtkorb E, Øye AM, Røsby O, Selmer KK (2014) CHD2 mutations in Lennox-Gastaut syndrome. Epilepsy Behav 33:18–21
Terrone G, Bienvenu T, Germanaud D, Barthez-Carpentier MA, Diebold B, Delanoe C et al (2014) A case of Lennox-Gastaut syndrome in a patient with FOXG1-related disorder. Epilepsia 55(11):e116–e119
von Spiczak S, Helbig KL, Shinde DN, Huether R, Pendziwiat M, Lourenço C, Epi4K Consortium, EuroEPINOMICS-RES NLES Working Group et al (2017) DNM1 encephalopathy: a new disease of vesicle fission. Neurology 89(4):385–394
Nieh SE, Sherr EH (2014) Epileptic encephalopathies: new genes and new pathways. Neurotherapeutics 11(4):796–806
Archer JS, Warren AE, Stagnitti MR, Masterton RA, Abbott DF, Jackson GD (2014) Lennox-Gastaut syndrome and phenotype: secondary network epilepsies. Epilepsia 55(8):1245–1254
Pillay N, Archer JS, Badawy RA, Flanagan DF, Berkovic SF, Jackson G (2013) Networks underlying paroxysmal fast activity and slow spike and wave in Lennox-Gastaut syndrome. Neurology 81(7):665–673
Warren AE, Abbott DF, Vaughan DN, Jackson GD, Archer JS (2016) Abnormal cognitive network interactions in Lennox-Gastaut syndrome: a potential mechanism of epileptic encephalopathy. Epilepsia 57(5):812–822
Oguni H, Hayashi K, Osawa M (1996) Long-term prognosis of Lennox-Gastaut syndrome. Epilepsia 37(suppl 3):44–47
Glauser TA (2004) Following catastrophic epilepsy patients from childhood to adulthood. Epilepsia 45(Suppl. 5):23–26
Intusoma U, Abbott DF, Masterton RA, Stagnitti MR, Newton MR, Jackson GD et al (2013) Tonic seizures of Lennox-Gastaut syndrome: periictal single-photon emission computed tomography suggests a corticopontine network. Epilepsia 54(12):2151–2157
Bare MA, Glauser TA, Strawsburg RH (1998) Need for electroencephalogram video confirmation of atypical absence seizures in children with Lennox-Gastaut syndrome. J Child Neurol 13(10):498–500
Hoffmann-Riem M, Diener W, Benninger C, Rating D, Unnebrink K, Stephani U et al (2000) Nonconvulsive status epilepticus—a possible cause of mental retardation in patients with Lennox-Gastaut syndrome. Neuropediatrics 31(4):169–174
Asadi-Pooya AA, Dlugos D, Skidmore C, Sperling MR (2017) Atlas of electroencephalography, 3rd edition. Epileptic Disord 19(3):384
Wirrell E, Farrell K, Whiting S (2005) The epileptic encephalopathies of infancy and childhood. Can J Neurol Sci 32(4):409–418
Pavone P, Striano P, Falsaperla R, Pavone L, Ruggieri M (2014) Infantile spasms syndrome, West syndrome and related phenotypes: what we know in 2013. Brain and Development 36(9):739–751
Kerr M, Kluger G, Philip S (2011) Evolution and management of Lennox-Gastaut syndrome through adolescence and into adulthood: are seizures always the primary issue? Epileptic Disord 13(Suppl 1):S15–S26
Michoulas A, Farrell K (2010) Medical management of Lennox-Gastaut syndrome. CNS Drugs 24(5):363–374
Felbamate Study Group (1993) Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 328:29–33
Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P (1997) Lamotrigine for generalized seizures associated with Lennox-Gastaut syndrome. N Engl J Med 337:1807–1812
Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger GA (1999) Double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 52:1882–1887
Glauser T, Kluger G, Sachdeo R et al (2008) Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 70(21):1950–1958
Ng YT, Conry J, Mitchell WG, Buchhalter J, Isojarvi J, Lee D et al (2015) Clobazam is equally safe and efficacious for seizures associated with Lennox-Gastaut syndrome across different age groups: post hoc analyses of short- and long-term clinical trial results. Epilepsy Behav 46:221–226
Asadi-Pooya AA, Sperling MR (2016) Antiepileptic drugs: a clinician’s manual, 2nd edn. Oxford University Press, New York
Marson AG, Al-Kharusi AM, Alwaidh M (2007) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomized controlled trial. Lancet 369:1016–1026
Asadi-Pooya AA, Emami M, Ashjazadeh N, Nikseresht A, Shariat A, Petramfar P et al (2013) Reasons for uncontrolled seizures in adults; the impact of pseudointractability. Seizure 22(4):271–274
Andrade-Machado R, Luque-Navarro-de los Reyes J, Benjumea-Cuartas V, Restrepo JF, Jaramillo-Jiménez E, Andrade-Gutierrez G et al (2015) Efficacy and tolerability of add-on Lacosamide treatment in adults with Lennox-Gastaut syndrome: an observational study. Seizure 33:81–87
Faulkner MA (2015) Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox-Gastaut syndrome. Ther Clin Risk Manag 8:905–914
Wheless JW, Isojarvi J, Lee D, Drummond R, Benbadis SR (2014) Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience. Epilepsy Behav 41:47–52
VanStraten AF, Ng YT (2012) Update on the management of Lennox-Gastaut syndrome. Pediatr Neurol 47(3):153–161
Jaraba S, Santamarina E, Miró J, Toledo M, Molins A, Burcet J et al (2017) Rufinamide in children and adults in routine clinical practice. Acta Neurol Scand 135(1):122–128
Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J et al (2016) Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol 15(3):270–278
Pera MC, Randazzo G, Masnada S, Dontin SD, De Giorgis V, Balottin U et al (2015) Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy. Funct Neurol 30(3):173–179
Mikati MA, Kurdi R, El-Khoury Z, Rahi A, Raad W (2010) Intravenous immunoglobulin therapy in intractable childhood epilepsy: open-label study and review of the literature. Epilepsy Behav 17(1):90–94
Caraballo RH, Fortini S, Fresler S, Armeno M, Ariela A, Cresta A et al (2014) Ketogenic diet in patients with Lennox-Gastaut syndrome. Seizure 23(9):751–755
Kossoff EH, Shields WD (2014) Nonpharmacologic care for patients with Lennox-Gastaut syndrome: ketogenic diets and vagus nerve stimulation. Epilepsia 55(Suppl 4):29–33
Sharma S, Jain P, Gulati S, Sankhyan N, Agarwala A (2015) Use of the modified Atkins diet in Lennox Gastaut syndrome. J Child Neurol 30(5):576–579
Kim SH, Kang HC, Lee EJ, Lee JS, Kim HD (2017) Low glycemic index treatment in patients with drug-resistant epilepsy. Brain Dev. https://doi.org/10.1016/j.braindev.2017.03.027
Douglass LM, Salpekar J (2014) Surgical options for patients with Lennox-Gastaut syndrome. Epilepsia 55(Suppl 4):21–28
Gupta A, Chirla A, Wyllie E, Lachhwani DK, Kotagal P, Bingaman WE (2007) Pediatric epilepsy surgery in focal lesions and generalized electroencephalogram abnormalities. Pediatr Neurol 37(1):8–15
Wyllie E, Lachhwani DK, Gupta A, Chirla A, Cosmo G, Worley S et al (2007) Successful surgery for epilepsy due to early brain lesions despite generalized EEG findings. Neurology 69(4):389–397
Ostendorf AP, Ng YT (2017) Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions. Neuropsychiatr Dis Treat 13:1131–1140
Hong J, Desai A, Thadani VM, Roberts DW (2017) Efficacy and safety of corpus callosotomy after vagal nerve stimulation in patients with drug-resistant epilepsy. J Neurosurg 3:1–10. https://doi.org/10.3171/2016.10.JNS161841
Katagiri M, Iida K, Kagawa K, Hashizume A, Ishikawa N, Hanaya R et al (2016) Combined surgical intervention with vagus nerve stimulation following corpus callosotomy in patients with Lennox-Gastaut syndrome. Acta Neurochir 158(5):1005–1012
Van Wagenen WP, Herren RY (1940) Surgical division of commissural pathways in the corpus callosum: relation to spread of an epileptic attack. Arch Neurol Psychiatr 44:740–759
Wada JA (1995) Midline subcortical structures for transhemispheric ictal and interictal transmission. In: Reeves AG, Roberts DW (eds) Epilepsy and the corpus callosum 2. Advances in behavioral biology, vol 45. Plenum, New York, pp 61–78
Asadi-Pooya AA, Sharan A, Nei M, Sperling MR (2008) Corpus callosotomy. Epilepsy Behav 13:271–278
Asadi-Pooya AA, Malekmohamadi Z, Kamgarpour A, Rakei SM, Taghipour M, Ashjazadeh N et al (2013) Corpus callosotomy is a valuable therapeutic option for patients with Lennox-Gastaut syndrome and medically-refractory seizures. Epilepsy Behav 29(2):285–288
Terra VC, Amorim R, Silvado C, Oliveira AJ, Jorge CL, Faveret E et al (2013) Vagus nerve stimulator in patients with epilepsy: indications and recommendations for use. Arq Neuropsiquiatr 71(11):902–906
Henry TR, Votaw JR, Pennell PB, Epstein CM, Bakay RA, Faber TL et al (1999) Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology 52:1166–1173
Henry TR, Bakay RA, Pennell PB, Epstein CM, Votaw JR (2004) Brain blood-flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: II. Prolonged effects at high and low levels of stimulation. Epilepsia 45(9):1064–1070
Orosz I, McCormick D, Zamponi N, Varadkar S, Feucht M, Parain D et al (2014) Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia 55(10):1576–1584
García-Navarrete E, Torres CV, Gallego I, Navas M, Pastor J, Sola RG (2013) Long-term results of vagal nerve stimulation for adults with medication-resistant epilepsy who have been on unchanged antiepileptic medication. Seizure 22(1):9–13
Cukiert A, Cukiert CM, Burattini JA, Lima AM, Forster CR, Baise C et al (2013) Long-term outcome after callosotomy or vagus nerve stimulation in consecutive prospective cohorts of children with Lennox-Gastaut or Lennox-like syndrome and non-specific MRI findings. Seizure 22(5):396–400
Lancman G, Virk M, Shao H, Mazumdar M, Greenfield JP, Weinstein S et al (2013) Vagus nerve stimulation vs. corpus callosotomy in the treatment of Lennox-Gastaut syndrome: a meta-analysis. Seizure 22(1):3–8
Kim HJ, Kim HD, Lee JS, Heo K, Kim DS, Kang HC (2015) Long-term prognosis of patients with Lennox-Gastaut syndrome in recent decades. Epilepsy Res 110:10–19
Piña-Garza JE, Montouris GD, Vekeman F, Cheng WY, Tuttle E, Giguere-Duval P et al (2017) Assessment of treatment patterns and healthcare costs associated with probable Lennox-Gastaut syndrome. Epilepsy Behav 73:46–50
Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L et al (2017) ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58(4):512–521
Cavazzuti GB (2003) Infantile encephalopathies. Neurol Sci 24:S244–S245
Franzini A, Cordella R, Messina G, Marras CE, Romito LM, Albanese A et al (2012) Targeting the brain: considerations in 332 consecutive patients treated by deep brain stimulation (DBS) for severe neurological diseases. Neurol Sci 33(6):1285–1303